Global X S&P 500 U.S. Market Leaders TOP 50 ETF FLAG
29.91 USD +0.76 (+2.60%)
Nov 4, 2026, 10:56 AM EST
29.15 Day range 29.15
25.57 52-week range 29.23
- YTD
- +8.05%
- 1 year
- +8.20%
- Market cap
- 1.75M
- EPS (ttm)
- 1.22
- Shares out
- 4.13M
- P/E ratio
- 23.85
- YTD return
- +8.05%
- 1-year return
- +8.20%
- Volume
- 13
- Avg volume
- 193
- Open
- 29.03
- Previous close
- 29.15
- Day's range
- 29.15 – 29.15
- 52-week range
- 25.57 – 29.23
2Y +4.47 (+18.11%)
Key statistics
- Enterprise value
- 105.10M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 82.83K
- Total debt
- 1.46M
- Return on equity
- 0.00%
- Short % of float
- 0.01%
- 50-day average
- 10.40
- 200-day average
- 10.19
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
FLAG Revenue — quarterly 0
FLAG Net income — quarterly -4.27M
FLAG EPS — quarterly -0.46
About Global X S&P 500 U.S. Market Leaders TOP 50 ETF
First Light Acquisition Group, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is headquartered in Reston, Virginia.
- Sector
- Financial Services
- Industry
- Shell Companies
- Country
- United States
- Website
- firstlightacquisition.com
News
FLAG Improves Undersea Connectivity between Key Markets with Ciena WaveLogic 6 
Innovation In Indexing: Why Passive ETFs Matter 
Global X Doubles Down On Domestic Strength With New ETF Pair 
When Domestic ETF Bias Meets Intentional International Exposure 
Global X Launches 2 Domestic-Focused ETFs 
Calidi Biotherapeutics Debuts as a Publicly Traded Company Focused on Arming the Immune System to Fight Cancer with a New Generation of Targeted Immunotherapies 
First Light Acquisition Group Announces NYSE Approval For Listing Of Business Combination With Calidi Biotherapeutics And Additional New Capital Commitments 
First Light Acquisition Group Announces NYSE Approval for Listing of Business Combination with Calidi Biotherapeutics and Additional New Capital Commitments 
Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session 
US Stocks Mostly Flat; Best Buy Posts Upbeat Results
Your note
Sign in to keep a note on FLAG — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| POLAR ASSET MANAGEMENT PARTNERS INC | Beneficial Owner of more than 10% of a Class of Security | Sale | Oct 18, 2022 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Hudson Bay Capital Management Lp | 12.11% | 500,000 | 5.26M | Mar 30, 2023 |
| Polar Asset Management Partners Inc. | 10.00% | 412,800 | 4.34M | Mar 30, 2023 |
| Woodline Partners LP | 9.69% | 400,000 | 4.21M | Mar 30, 2023 |
| Glazer Capital LLC | 9.08% | 374,900 | 3.94M | Mar 30, 2023 |
| Kim, LLC | 8.63% | 356,098 | 3.75M | Mar 30, 2023 |
| Bank of Montreal/Can/ | 7.67% | 316,628 | 3.33M | Dec 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Investment Managers Ser Tr II-First Trust Merger Arbitrage Fd | 1.34% | 385,000 | 4.05M | Dec 30, 2022 |
| Driehaus Event Driven Fund | 0.24% | 68,127 | 716.70K | Dec 30, 2022 |
| AQR Funds-AQR Diversified Arbitrage Fd | 0.14% | 40,464 | 425.68K | Dec 30, 2022 |